2025
Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome
Zhang Z, Hu X, Du Q, Mo P, Chen X, Luo M, Jiang Q, Deng L, Xiong Y. Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome. BMC Infectious Diseases 2025, 25: 508. PMID: 40217170, PMCID: PMC11992865, DOI: 10.1186/s12879-025-10900-y.Peer-Reviewed Original ResearchConceptsDisseminated intravascular coagulationOutcomes of disseminated intravascular coagulationPresence of disseminated intravascular coagulationNon-DIC groupIndependent risk factorIntravascular coagulationClinical characteristicsRisk factorsDisseminated intravascular coagulation groupThrombocytopenia syndromeMultivariate logistic regression analysisAssociated with high mortalityIn-hospital mortality of patientsCumulative survival rateZhongnan Hospital of Wuhan UniversityMortality of patientsIn-Hospital MortalitySevere feverLogistic regression analysisConsecutive patientsFerritin levelsD-dimerViral loadClinical dataCystatin C
2023
A New Model for Diagnosing Sepsis-induced Disseminated Intravascular Coagulation (DIC) in Patients With Coagulopathy of Liver Disease--Moving Away From Factor VIII (FVIII) and International Society on Thrombosis and Hemostasis (ISTH) DIC Scores
Allen C, Heskel M, Butt A, Pine A, Lee A, Gautam S. A New Model for Diagnosing Sepsis-induced Disseminated Intravascular Coagulation (DIC) in Patients With Coagulopathy of Liver Disease--Moving Away From Factor VIII (FVIII) and International Society on Thrombosis and Hemostasis (ISTH) DIC Scores. 2023, a6391-a6391. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6391.Peer-Reviewed Original Research
2022
Plasma and Platelet Transfusion Strategies in Critically Ill Children With Malignancy, Acute Liver Failure and/or Liver Transplantation, or Sepsis: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding
Lieberman L, Karam O, Stanworth SJ, Goobie SM, Crighton G, Goel R, Lacroix J, Nellis ME, Parker RI, Steffen K, Stricker P, Valentine SL, Steiner ME, Network A. Plasma and Platelet Transfusion Strategies in Critically Ill Children With Malignancy, Acute Liver Failure and/or Liver Transplantation, or Sepsis: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding. Pediatric Critical Care Medicine 2022, 23: e37-e49. PMID: 34989704, PMCID: PMC8769367, DOI: 10.1097/pcc.0000000000002857.Peer-Reviewed Original ResearchConceptsAnemia EXpertise Initiative-Control/AvoidanceAcute liver diseaseLiver transplantationExpert consensus statementLiver diseaseIntravascular coagulationIll neonatesPlatelet transfusionsIll childrenConsensus statementSystematic reviewLos Angeles Appropriateness MethodExpert-based statementsAcute liver failurePlatelet transfusion strategyDevelopment/UniversityCochrane Library databasesBleeding expertsRecommendations AssessmentTransfusion strategyLiver failureTransfusion managementAppropriateness MethodTransfusionSepsis
2020
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP, Zeidan AM. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells 2020, 9: 2310. PMID: 33080779, PMCID: PMC7603052, DOI: 10.3390/cells9102310.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTumor lysis syndromeAcute myeloid leukemiaLeukemic blastsMyeloid leukemiaCell adhesion moleculeAggressive intravenous fluid hydrationWhite blood cell countEndothelial cellsAdhesion moleculesDevelopment of leukostasisIntravenous fluid hydrationManagement of DICMainstay of therapyLife-threatening complicationsBlood cell countLeukemic stem cell survivalBone marrow microenvironmentIntensive chemotherapyIntravascular coagulationLysis syndromeFluid hydrationSupportive treatmentAdverse prognosisAML patientsInflammatory cytokinesLeukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits
Shallis RM, Stahl M, Bewersdorf JP, Hendrickson JE, Zeidan AM. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Review Of Hematology 2020, 13: 489-499. PMID: 32248712, DOI: 10.1080/17474086.2020.1751609.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsWhite blood cell countAcute myeloid leukemiaTumor lysis syndromeMyeloid leukemiaPeripheral white blood cell countEvidence-based clinical guidelinesTotal white blood cell countEnd-organ damageRelevant patient outcomesWide practice variationBlood cell countPeripheral myeloblastsLysis syndromeIntravascular coagulationSurvival benefitOrgan damageClinical guidelinesPatient outcomesPractice variationLeukocytapheresisHigh riskCytoreductive strategyCell countHyperleukocytosisCells/L
2019
Hyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1147-1153. DOI: 10.1007/978-3-319-74588-6_94.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cellsSevere maternal morbidity during delivery hospitalisation in a large international administrative database, 2008–2013: a retrospective cohort
Lipkind H, Zuckerwise L, Turner E, Collins J, Campbell K, Reddy U, Illuzi J, Merriam A. Severe maternal morbidity during delivery hospitalisation in a large international administrative database, 2008–2013: a retrospective cohort. BJOG An International Journal Of Obstetrics & Gynaecology 2019, 126: 1223-1230. PMID: 31100201, DOI: 10.1111/1471-0528.15818.Peer-Reviewed Original ResearchMeSH KeywordsAdultAustraliaCenters for Disease Control and Prevention, U.S.ComorbidityDatabases, FactualEnglandFemaleHospitalizationHumansMaternal AgeMaternal DeathMiddle AgedObstetric Labor ComplicationsPregnancyPregnancy ComplicationsPregnancy OutcomeRetrospective StudiesRisk FactorsUnited StatesYoung AdultConceptsSevere maternal morbidityMaternal morbidityDelivery hospitalisationRetrospective cohortRisk factorsSevere maternal morbidity ratesMaternal morbidity ratesAcute renal failureLife-threatening diagnosisAdvanced maternal ageLife-saving procedureLarge university hospitalChi-square testMorbidity variesPregnancy complicationsClinical characteristicsIntravascular coagulationRenal failureSevere morbidityMultivariable analysisMorbidity rateAdverse outcomesClinical differencesMaternal ageUniversity HospitalPneumococcal Bacteremia Complicated by Hemophagocytic Lymphohistiocytosis
Howard F, Sankey C. Pneumococcal Bacteremia Complicated by Hemophagocytic Lymphohistiocytosis. Journal Of General Internal Medicine 2019, 34: 1653-1657. PMID: 31011972, PMCID: PMC6667527, DOI: 10.1007/s11606-019-05001-x.Peer-Reviewed Case Reports and Technical NotesConceptsHemophagocytic lymphohistiocytosisStreptococcal infectionOccult sinusitisPneumococcal bacteremiaRecurrent pneumococcal infectionsS. pneumoniae bacteremiaSevere streptococcal infectionsIntroduction of vaccinesEffective antibiotic treatmentGeneral medical practitionersPneumoniae bacteremiaIntravascular coagulationPneumococcal infectionAntibiotic treatmentPyogenic diseaseStreptococcus pneumoniaeBacteremiaInfectionCausative agentLymphohistiocytosisSuch predispositionSinusitisMedical practitionersIllness scriptsSepsisHyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1-7. DOI: 10.1007/978-3-319-74698-2_94-1.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cells
2018
Pharmacoinformatic Approach to Explore the Antidote Potential of Phytochemicals on Bungarotoxin from Indian Krait, Bungarus caeruleus
Rajendran B, Suresh M, Bhaskaran S, Harshitha Y, Gaur U, Kwok H. Pharmacoinformatic Approach to Explore the Antidote Potential of Phytochemicals on Bungarotoxin from Indian Krait, Bungarus caeruleus. Computational And Structural Biotechnology Journal 2018, 16: 450-461. PMID: 30455855, PMCID: PMC6231056, DOI: 10.1016/j.csbj.2018.10.005.Peer-Reviewed Original ResearchPharmacoinformatics approachIntravascular coagulationLocal symptomsBioactive phytochemical compoundsRespiratory arrestRespiratory paralysisMinor symptomsAllergic responsesTissue injurySevere symptomsEffective analytical toolVenomous toxinsHerbal compoundsBungarotoxinMolecular dynamicsAdverse effectsSymptomsBlood coagulationNeurotoxic proteinsBungarus caeruleusPoisonous snakesPropanoic acidIndian kraitIndole-3Structural insightsDisseminated Intravascular Coagulation
Hossain N, Paidas M. Disseminated Intravascular Coagulation. 2018, 479-486. DOI: 10.1002/9781119129400.ch31.Peer-Reviewed Original ResearchDisseminated intravascular coagulationAmniotic fluid embolismIntravascular coagulationDiagnosis of DICLow platelet count syndromeObstetrical disseminated intravascular coagulationTissue factorMicrovesicular fatty infiltrationAcute fatty liverElevated liver enzymesMassive obstetric hemorrhageSignificant maternal mortalityObstetric causesObstetric hemorrhageSupportive careBlood lossCatastrophic complicationLiver failureMedical complicationsFatty liverFatty infiltrationMaternal hepatocytesMaternal mortalityLiver enzymesBlood productsDevelopment of a Quantitative Assay for the Characterization of Human Collectin-11 (CL-11, CL-K1)
Bayarri-Olmos R, Kirketerp-Moller N, Pérez-Alós L, Skjodt K, Skjoedt M, Garred P. Development of a Quantitative Assay for the Characterization of Human Collectin-11 (CL-11, CL-K1). Frontiers In Immunology 2018, 9: 2238. PMID: 30323815, PMCID: PMC6172411, DOI: 10.3389/fimmu.2018.02238.Peer-Reviewed Original ResearchMeSH KeywordsAnalysis of VarianceAnimalsAntibodies, MonoclonalCHO CellsChromatography, GelCollectinsComplement C4CricetulusEnzyme-Linked Immunosorbent AssayFreezingHumansLectinsMannose-Binding Protein-Associated Serine ProteasesProtein BindingStatistics, NonparametricSystemic Inflammatory Response SyndromeZymosanConceptsPlasma levelsSystemic inflammatory response syndromeQuantitative ELISACL-11Immunoprecipitation of serumDisseminated intravascular coagulationInflammatory response syndromeMean plasma concentrationCollectin-11Pattern recognition moleculesIntravascular coagulationResponse syndromeIntensive careUrinary schistosomiasisHealthy controlsPlasma concentrationsClinical toolHost defenseSensitive ELISAMonoclonal antibodiesELISACongenital disorderSignificant decreaseLectin pathwayZymosanOptimal maternal and neonatal outcomes and associated hospital characteristics
Campbell KH, Illuzzi JL, Lee HC, Lin H, Lipkind HS, Lundsberg LS, Pettker CM, Xu X. Optimal maternal and neonatal outcomes and associated hospital characteristics. Birth 2018, 46: 289-299. PMID: 30251270, DOI: 10.1111/birt.12400.Peer-Reviewed Original ResearchMeSH KeywordsAdultBirth CertificatesCaliforniaCesarean SectionFemaleGestational AgeHospitalsHumansInfant, NewbornInfant, Newborn, DiseasesMorbidityObstetric Labor ComplicationsObstetricsPatient DischargePoisson DistributionPregnancyQuality Indicators, Health CareRegression AnalysisRisk FactorsYoung AdultConceptsRisk-standardized ratesMorbidity rateNeonatal outcomesObstetrical performancePatient clinical risk factorsFuture quality improvement effortsMaternal morbidity ratesNeonatal morbidity ratesProcedures/surgeriesSevere newborn morbiditySevere maternal morbidityClinical risk factorsShock/resuscitationHospital discharge recordsMaternal-newborn outcomesQuality improvement effortsPrevalent morbidityMaternal morbidityNeonatal morbidityRespiratory complicationsIntravascular coagulationNewborn morbidityHeart failureTerm birthsHospital variationRadical treatment of primary type B aortic dissection or after thoracic endovascular aortic repair to manage disseminated intravascular coagulation
Wang L, Liu F, Guo D, Xu D, Zhou X, Hou K, Zhang W, Shi Z, Tang X, Fu W. Radical treatment of primary type B aortic dissection or after thoracic endovascular aortic repair to manage disseminated intravascular coagulation. Journal Of Thoracic Disease 2018, 10: 3808-3813. PMID: 30069381, PMCID: PMC6051806, DOI: 10.21037/jtd.2018.06.93.Peer-Reviewed Original ResearchType B aortic dissectionDisseminated intravascular coagulationB aortic dissectionEndovascular repair techniquesIntravascular coagulationFL thrombosisThoracic endovascular aortic repairClinical data of patientsStable aortic diametersEndovascular aortic repairData of patientsRepair techniquesAortic repairAortic diameterFatal complicationRadical treatmentEndovascular techniquesFollow-upClinical dataDissectionThrombosisPatientsTearsCoagulationComplications
2016
Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential
Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Human Pathology 2016, 54: 143-151. PMID: 27090685, PMCID: PMC5242228, DOI: 10.1016/j.humpath.2016.03.018.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkers, TumorCell ProliferationClass I Phosphatidylinositol 3-KinasesDiagnosis, DifferentialDNA Mutational AnalysisFemaleGTP-Binding Protein alpha Subunits, Gq-G11Hemangioma, CavernousHemangiosarcomaHumansImmunohistochemistryKi-67 AntigenLiver NeoplasmsMaleMiddle AgedMutationNeoplasm GradingPhosphatidylinositol 3-KinasesPredictive Value of TestsProto-Oncogene Proteins c-mycTerminology as TopicTumor Suppressor Protein p53Vascular NeoplasmsYoung AdultConceptsHepatic small vessel neoplasmMalignant potentialCavernous hemangiomaVascular neoplasmImmunohistochemical stainsProliferative indexKi-67 proliferative indexTumour cell proliferative indexDisseminated intravascular coagulationKasabach-Merritt syndromePossible malignant potentialLow-grade tumorsUncertain malignant potentialRare vascular neoplasmCapture-based next-generation sequencingHistologic differential diagnosisCell proliferative indexC-myc stainingStrong p53Intravascular coagulationComplete resectionHepatic angiosarcomaDifferential diagnosisInfiltrative bordersAngiosarcoma
2015
Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Ong SY, Taverna J, Jokerst C, Enzler T, Hammode E, Rogowitz E, Green MR, Babiker HM. Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix. Case Reports In Oncological Medicine 2015, 2015: 212543. PMID: 26613055, PMCID: PMC4646996, DOI: 10.1155/2015/212543.Peer-Reviewed Original ResearchDisseminated intravascular coagulationProstate cancerIntravascular coagulationExcessive fibrinolysisGonadotropin-releasing hormone receptor antagonistTherapeutic drug optionsHormone receptor antagonistLife-threatening variantDays of treatmentHemorrhagic complicationsSystemic bleedingDrug optionsReceptor antagonistPatient's coagulopathySingle injectionCoagulopathyDegarelixPatientsFibrinolysisCancerCoagulationBleedingComplicationsAntagonistHypofibrinogenemia
2014
Severe falciparum malaria associated with massive pulmonary embolism
Musoke C, Ssendikadiwa C, Babua C, Schwartz JI. Severe falciparum malaria associated with massive pulmonary embolism. Annals Of African Medicine 2014, 13: 47-49. PMID: 24521579, DOI: 10.4103/1596-3519.126952.Peer-Reviewed Original Research
2011
A challenging case of gastric outlet obstruction (Bouveret's syndrome): a case report
Gajendran M, Muniraj T, Gelrud A. A challenging case of gastric outlet obstruction (Bouveret's syndrome): a case report. Journal Of Medical Case Reports 2011, 5: 497. PMID: 21970809, PMCID: PMC3204302, DOI: 10.1186/1752-1947-5-497.Peer-Reviewed Original ResearchBouveret's syndromeGastric outlet obstructionSmall bowel obstructionElevated alkaline phosphataseCase presentationAnBowel obstructionRespiratory failureCholedochoduodenal fistulaGallstone ileusIntravascular coagulationLaboratory workupOutlet obstructionPostoperative courseConsiderable morbidityDistal duodenumBiliary tractCardiopulmonary arrestConclusionThis caseHigh morbidityAmylase levelsCase reportMyocardial infarctionCaucasian womenEarly recognitionImpacted gallstone
2010
Disseminated Intravascular Coagulation
Hossain N, Paidas M. Disseminated Intravascular Coagulation. 2010, 182-194. DOI: 10.1002/9781444328332.ch10.Peer-Reviewed Original ResearchDisseminated intravascular coagulationIntravascular coagulationEndothelial damageBlood productsAmniotic fluid embolismTransfusion of bloodAbruptio placentaeObstetric patientsHemorrhagic shockSystemic activationPrimary disorderFluid balanceIntravascular thrombiCoagulation factorsMultidisciplinary approachPregnancyPatientsObstetricsCoagulationBloodDisordersCorrect useLaboratory assaysConsequences of consumptionCoagulopathy
1999
Immunobiology of human vascular endothelium
Pober J. Immunobiology of human vascular endothelium. Immunologic Research 1999, 19: 225-232. PMID: 10493176, DOI: 10.1007/bf02786490.Peer-Reviewed Original ResearchConceptsVascular endothelial cellsEndothelial cellsImmune reactionsCell-mediated immune reactionsPeptide-major histocompatibility complex complexesImmune effector mechanismsMemory T cellsSecondary immune reactionT cell signalsConsequences of infectionHuman vascular endotheliumHuman T lymphocytesHuman tissue specimensAllograft rejectionIntravascular coagulationAllogeneic transplantationEffector cellsNew effector functionsEffector mechanismsLeukocyte recruitmentImmune surveillanceT cellsT lymphocytesPeripheral tissuesEffector functions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply